Affordable Access

Publisher Website

Delayed Onset of Experimental Autoimmune Encephalomyelitis in Olig1 Deficient Mice

Public Library of Science
Publication Date
DOI: 10.1371/journal.pone.0013083
  • Research Article
  • Biochemistry
  • Ophthalmology
  • Neuroscience/Neuronal And Glial Cell Biology
  • Physiology/Sensory Systems
  • Neurological Disorders/Multiple Sclerosis And Related Disorders
  • Neurological Disorders/Neuro-Ophthalmology And Neuro-Otology
  • Neurological Disorders/Spinal Disorders
  • Biology
  • Medicine


Background Olig1 is a basic helix-loop-helix (bHLH) transcription factor that is essential for oligodendrogenesis and efficient remyelination. However, its role in neurodegenerative disorders has not been well-elucidated. Methodology/Principal Findings Here we investigated the effects of Olig1 deficiency on experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). We show that the mean disease onset of myelin oligodendrocyte glycoprotein (MOG)-induced EAE in Olig1−/− mice is significantly slower than wide-type (WT) mice (19.8±2.2 in Olig1−/− mice and 9.5±0.3 days in WT mice). In addition, 10% of Olig1−/− mice did not develop EAE by the end of the observation periods (60 days). The severity of EAE, the extent of demyelination, and the activation of microglial cells and astrocytes in spinal cords, were significantly milder in Olig1−/− mice compared with WT mice in the early stage. Moreover, the visual function, as assessed by the second-kernel of multifocal electroretinograms, was better preserved, and the number of degenerating axons in the optic nerve was significantly reduced in Olig1−/− mice. Interestingly, Olig1 deficiency had no effect on T cell response capability, however, it reduced the expression of myelin proteins such as MOG, myelin basic protein (MBP) and myelin-associated glycoprotein (MAG). The expression of Olig2 remained unchanged in the optic nerve and brain, and it was reduced in the spinal cord of Olig1−/− mice. Conclusions/Significance Our results suggest that the Olig1 signaling pathways may be involved in the incidence rate and the severity of neurological symptoms in MS.

There are no comments yet on this publication. Be the first to share your thoughts.